Department of Animal Biotechnology, Lala Lajpar Rai University of Veterinary and Animal Sciences, Hisar 125004, Haryana, India.
APR Division, Indian Council of Agricultural Research-Central Research Institute on Buffaloes, Hisar 125001, Haryana, India.
J Nanosci Nanotechnol. 2021 Jun 1;21(6):3404-3452. doi: 10.1166/jnn.2021.18999.
Emergence of multidrug resistance (MDR), extensively drug resistance (XDR) and pandrug resistance (PDR) strains of bacteria in communicable diseases of zoonotic and reverse zoonotic importance is the major hurdle of one health concept. Increasing level of resistance against antibiotics among bacterial population throughout the world, slow pace of new antibacterial drug discovery and enhanced pace of resistance development by pathogenic bacteria possess major challenges for human and animal health as well as life in future. Alternative management strategy in terms of improved prophylactic vaccine; early, easy and effective diagnostics and therapeutic drugs against those resistant bacteria is the need of the hour. In this context nanomedicine can fit into the multifaceted demands as an effective prophylactic and theranostic alternative to control the communicable diseases in a cost effective manner in the era of microbial resistance. The current review is focused towards delineating the application of nanomaterials as vaccine or drug delivery system, diagnostics and directly acting antimicrobial therapeutic agents in combating the important zoonotic and reverse zoonotic bacterial diseases in recent scenario along with their potential benefits, limitations and future prospects to formulate successful eradication strategies.
传染病中具有动物源性和反向动物源性重要性的耐多药(MDR)、广泛耐药(XDR)和泛耐药(PDR)细菌株的出现,是“同一健康”概念的主要障碍。全球细菌对抗生素的耐药性水平不断提高,新抗菌药物的发现速度缓慢,而致病菌的耐药性发展速度加快,这对人类和动物健康以及未来的生活构成了重大挑战。针对这些耐药菌,改进预防性疫苗;早期、简便、有效的诊断和治疗药物,是当前的迫切需求。在这方面,纳米医学可以满足多方面的需求,作为一种有效的预防和治疗替代方法,以在微生物耐药的时代以具有成本效益的方式控制传染病。目前的综述重点阐述了纳米材料在疫苗或药物输送系统、诊断以及直接作用的抗菌治疗剂方面的应用,以对抗当前重要的动物源性和反向动物源性细菌疾病,以及它们在制定成功的根除策略方面的潜在益处、局限性和未来前景。